Sangamo Therapeutics, Inc.

SGMO

NASDAQ

Healthcare

Biotechnology

Richmond, CA, US183 employeessangamo.com

$0.30

+0.04(15.38%)

Mkt Cap $112M

$0.25

$0.81

52-Week Range

AI-generated

Sangamo Therapeutics reported lower year-over-year revenue and a widened net loss for FY2025, with near-term funding required to sustain operations and advance its pipeline.

Revenue breakdown: License (93.8%), Initial License (5.6%), Service (0.5%).

$112MMkt Cap

$40MRev TTM

-$133MNI TTM

-0.9xP/E

Latest Earnings

10-K

FY FY2025Mar 29, 2026

Sangamo Therapeutics reported lower year-over-year revenue and a widened net loss for FY2025, with near-term funding required to sustain operations and advance its pipeline.

Read full analysis View SEC Filing

What Changed Recently

Financial Results

Mar 29, 2026

and in the Press Release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference into any filing with the Securities

Material Agreement

Feb 3, 2026

Entry into a Material Definitive Agreement. Underwritten Offering On February 3, 2026, Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) entered into an u

Financial Results

Feb 2, 2026

shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by speci

Other Event

Feb 2, 2026

Other Events. On February 3, 2026, Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) announced the presentation of clinical data from its registrational P

Fundamentals

How The Business Makes Money

Revenue by Segment

License93.8%($235M)

Initial License5.6%($14M)

Service0.5%($1M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
ARMPArmata Pharmaceuticals, I...	$10.29	-2.60%	$377M	—
CCCCC4 Therapeutics, Inc.	$2.81	+4.26%	$233M	-2.0
OABIOmniAb, Inc.	$1.53	-1.60%	$175M	-3.5
IVVDInvivyd, Inc.	$1.27	-4.51%	$169M	-4.9
CDXSCodexis, Inc.	$1.79	+3.16%	$163M	-3.3
MOLNMolecular Partners AG	$3.85	-3.87%	$144M	-2.0
IPHAInnate Pharma S.A.	$1.37	+1.48%	$128M	-2.1
MISTMilestone Pharmaceuticals...	$1.38	+5.34%	$119M	-1.7

Company Profile

CIK0001001233

ISINUS8006771062

CUSIP800677106

Phone510 970 6000

Address501 Canal Blvd, Richmond, CA, 94005, US

SEC EDGAR